Assessment of the coding accuracy of warfarin-related bleeding events

被引:29
作者
Delate, Thomas [1 ]
Jones, Aubrey E. [1 ]
Clark, Nathan P. [1 ]
Witt, Daniel M. [2 ]
机构
[1] Kaiser Permanente Colorado, Dept Pharm, 16601 East Centretech Pkwy, Aurora, CO 80011 USA
[2] Univ Utah, Coll Pharm, Dept Pharmacotherapy, 30 2000 E, Salt Lake City, UT 84112 USA
关键词
Warfarin; Anticoagulation; Bleeding events; Diagnostic errors; Hospitals; CLASSIFICATION-OF-DISEASES; ADVERSE DRUG-REACTIONS; VENOUS THROMBOEMBOLISM; DEFINITION; VALIDATION; CODES;
D O I
10.1016/j.thromres.2017.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Using International Classification of Diseases, 9th edition (ICD-9) diagnosis codes to identify potential warfarin-related bleeding events from administrative datasets is highly efficient but may be prone to identifying non-events. The objective of this study was to evaluate the ability of bleeding-related ICD-9 codes to identify true bleeding events in patients who were receiving warfarin therapy at the time of hospitalization. Methods: This was a cross-sectional study conducted in an integrated healthcare delivery system. Anticoagulated patients aged >= 18 years and hospitalized between January 1, 2014 and March 31, 2014 were identified using administrative data queries. All hospitalizations were manually chart reviewed by a trained abstractor blinded to hospitalization diagnoses to assess for true bleeding events. Identification of the presence or lack of bleeding-related ICD-9 diagnosis code(s) for each hospitalization was then performed. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each ICD-9 code present. Results: There were 486 hospitalizations in 468 anticoagulated patients with 57 true bleeding events identified. Patients had a mean age of 73.4 years and 50% were female. For codes in the principal position, sensitivity, specificity, PPV, and NPV were 7.0%, 99.8%, 80.0%, and 89.0%, respectively. For codes in any position, sensitivity, specificity, PPV, and NPV were 94.7%, 90.9%, 58.1%, and 99.2%, respectively. For major bleeding, sensitivity, specificity, PPV, and NPV were 100%, 83.1%, 14.0%, and 100%, respectively. Conclusions: While the absence of a bleeding ICD-9 code reliably ruled-out hospitalization for warfarin-related bleeding, bleeding ICD-9 codes in the principal position were rarely used and undesirable false positive rates were identified when ICD-9 codes when recorded in any position and for major bleeding. Manual chart review is recommended to validate bleeding events from administrative data.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 19 条
[1]   Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Ageno, Walter ;
Gallus, Alexander S. ;
Wittkowsky, Ann ;
Crowther, Mark ;
Hylek, Elaine M. ;
Palareti, Gualtiero .
CHEST, 2012, 141 (02) :E44S-E88S
[2]   Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data [J].
Al-Ani, Fatimah ;
Shariff, Salimah ;
Siqueira, Lenicio ;
Seyam, Ayman ;
Lazo-Langner, Alejandro .
THROMBOSIS RESEARCH, 2015, 136 (06) :1195-1198
[3]   Accuracy of coding for possible warfarin complications in hospital discharge abstracts [J].
Arnason, T. ;
Wells, P. S. ;
van Walraven, C. ;
Forster, A. J. .
THROMBOSIS RESEARCH, 2006, 118 (02) :253-262
[4]   A CHRONIC DISEASE SCORE WITH EMPIRICALLY DERIVED WEIGHTS [J].
CLARK, DO ;
VONKORFF, M ;
SAUNDERS, K ;
BALUCH, WM ;
SIMON, GE .
MEDICAL CARE, 1995, 33 (08) :783-795
[5]   Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH [J].
Kaatz, S. ;
Ahmad, D. ;
Spyropoulos, A. C. ;
Schulman, S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (11) :2119-2126
[6]   Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10 [J].
Kokotailo, RA ;
Hill, MD .
STROKE, 2005, 36 (08) :1776-1781
[7]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[8]   A systematic review of validated methods to capture several rare conditions using administrative or claims data [J].
Lee, Christopher D. ;
Williams, S. Elizabeth ;
Sathe, Nila A. ;
McPheeters, Melissa L. .
VACCINE, 2013, 31 :K21-K27
[9]  
Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO
[10]  
2-I